These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 1588974)

  • 1. A transcriptionally active DNA-binding site for human p53 protein complexes.
    Funk WD; Pak DT; Karas RH; Wright WE; Shay JW
    Mol Cell Biol; 1992 Jun; 12(6):2866-71. PubMed ID: 1588974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.
    Furlong EE; Rein T; Martin F
    Mol Cell Biol; 1996 Oct; 16(10):5933-45. PubMed ID: 8816507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites.
    Gottschalk LR; Giannola DM; Emerson SG
    J Exp Med; 1993 Nov; 178(5):1681-92. PubMed ID: 8228815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
    Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
    Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.
    Suzuki T; Uchida-Toita M; Yoshida M
    Oncogene; 1999 Jul; 18(28):4137-43. PubMed ID: 10435595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel DNA binding of p53 mutants and their role in transcriptional activation.
    Zhang W; Funk WD; Wright WE; Shay JW; Deisseroth AB
    Oncogene; 1993 Sep; 8(9):2555-9. PubMed ID: 8361764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and p73 display common and distinct requirements for sequence specific binding to DNA.
    Lokshin M; Li Y; Gaiddon C; Prives C
    Nucleic Acids Res; 2007; 35(1):340-52. PubMed ID: 17170001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-dependent acetylation of p53 by the transcription coactivator p300.
    Dornan D; Shimizu H; Perkins ND; Hupp TR
    J Biol Chem; 2003 Apr; 278(15):13431-41. PubMed ID: 12499368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of p53 as a sequence-specific DNA-binding protein.
    Kern SE; Kinzler KW; Bruskin A; Jarosz D; Friedman P; Prives C; Vogelstein B
    Science; 1991 Jun; 252(5013):1708-11. PubMed ID: 2047879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor.
    Funk WD; Wright WE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9484-8. PubMed ID: 1329097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21/CDKN1A mediates negative regulation of transcription by p53.
    Löhr K; Möritz C; Contente A; Dobbelstein M
    J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.
    Johnson RA; Shepard EM; Scotto KW
    J Biol Chem; 2005 Apr; 280(14):13213-9. PubMed ID: 15634666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse DDA3 gene is a direct transcriptional target of p53 and p73.
    Hsieh SC; Lo PK; Wang FF
    Oncogene; 2002 May; 21(19):3050-7. PubMed ID: 12082536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.
    Uramoto H; Izumi H; Nagatani G; Ohmori H; Nagasue N; Ise T; Yoshida T; Yasumoto K; Kohno K
    Biochem J; 2003 Apr; 371(Pt 2):301-10. PubMed ID: 12534345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.
    Liu X; Miller CW; Koeffler PH; Berk AJ
    Mol Cell Biol; 1993 Jun; 13(6):3291-300. PubMed ID: 8497252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the human p11 promoter sequence.
    Huang X; Pawliczak R; Yao XL; Madara P; Alsaaty S; Shelhamer JH; Cowan MJ
    Gene; 2003 May; 310():133-42. PubMed ID: 12801640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53.
    Song LL; Alimirah F; Panchanathan R; Xin H; Choubey D
    Mol Cancer Res; 2008 Nov; 6(11):1732-41. PubMed ID: 18974396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human glucocorticoid receptor promoter upstream sequences contain binding sites for the ubiquitous transcription factor, Yin Yang 1.
    Breslin MB; Vedeckis WV
    J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):369-81. PubMed ID: 10030686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA modification with cisplatin affects sequence-specific DNA binding of p53 and p73 proteins in a target site-dependent manner.
    Pivonková H; Pecinka P; Cesková P; Fojta M
    FEBS J; 2006 Oct; 273(20):4693-706. PubMed ID: 16981908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.